SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001213900-22-029644
Filing Date
2022-05-26
Accepted
2022-05-26 09:28:26
Documents
5

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 ea160609-posam_raphaelpharma.htm POS AM 1047983
2 CONSENT OF BRIGHTMAN ALMAGOR ZOHAR & CO ea160609ex23-2_raphael.htm EX-23.2 2859
3 GRAPHIC image_001.jpg GRAPHIC 11599
4 GRAPHIC image_002.jpg GRAPHIC 33775
5 GRAPHIC image_003.jpg GRAPHIC 3892
  Complete submission text file 0001213900-22-029644.txt   1120170
Mailing Address SUITE 105 - 5348 VEGAS DR. LAS VEGAS NV 89108
Business Address SUITE 105 - 5348 VEGAS DR. LAS VEGAS NV 89108 702-442-1166
Raphael Pharmaceutical Inc. (Filer) CIK: 0001415397 (see all company filings)

IRS No.: 260204284 | State of Incorp.: NV | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-260766 | Film No.: 22965873
SIC: 2833 Medicinal Chemicals & Botanical Products